Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LRCX | Common Stock | Award | $0 | +5.07K | +4.96% | $0.00 | 107K | Mar 1, 2022 | Direct | F1, F2 |
transaction | LRCX | Common Stock | Tax liability | -$8.54M | -15.8K | -14.74% | $540.57 | 91.4K | Mar 1, 2022 | Direct | F2, F3 |
transaction | LRCX | Common Stock | Tax liability | -$714K | -1.32K | -1.45% | $540.57 | 90K | Mar 1, 2022 | Direct | F2, F3 |
transaction | LRCX | Common Stock | Tax liability | -$1.14M | -2.11K | -2.34% | $540.57 | 87.9K | Mar 1, 2022 | Direct | F2, F3 |
transaction | LRCX | Common Stock | Tax liability | -$1.11M | -2.01K | -2.28% | $554.02 | 85.9K | Mar 2, 2022 | Direct | F2, F3 |
holding | LRCX | Common Stock | 4.75K | Mar 1, 2022 | By 401(k) | ||||||
holding | LRCX | Common Stock | 561 | Mar 1, 2022 | By Spouse 401(k) |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LRCX | Market-based Performance Restricted Stock Unit | Award | $0 | +15.2K | $0.00 | 15.2K | Mar 1, 2022 | Common Stock | 15.2K | $0.00 | Direct | F4 | |
transaction | LRCX | Employee Stock Option (Right to Buy) | Award | $0 | +15.2K | $0.00 | 15.2K | Mar 1, 2022 | Common Stock | 15.2K | $540.57 | Direct | F5 |
Id | Content |
---|---|
F1 | The restricted stock units will vest in three equal installments on 03/01/2023, 03/01/2024, and 03/01/2025 |
F2 | The amount reported includes shares subject to unvested restricted stock units. |
F3 | Represents shares that were automatically withheld upon vesting of restricted stock units to satisfy tax withholding obligations. |
F4 | The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2025. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2022 through 01/31/2025. |
F5 | The stock options will become exercisable in three equal installments on 03/01/2023, 03/01/2024, and 03/01/2025. |